Latest total liabilities for OPTN: $180M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
OptiNose (OPTN) currently reports a total liabilities of $180M as of March 2025. That compares with $180M in the prior-year period — down 3.7% year over year. Use the charts on this page to explore OptiNose's total liabilities history and peer comparisons.
OptiNose's total liabilities decreased from $180M to $180M — a 3.7% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
OptiNose reported $180M in total liabilities as of March 2025. That compares with $180M in the prior-year period — down 3.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OptiNose, and consider following OPTN for alerts when major investors trade the stock.
OptiNose is classified in the Healthcare sector. On total liabilities, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OPTN with unrelated industries.